Table: begin end state 1 11 cytoplasmic 12 33 transmembrane 34 44 non-cytoplasmic 45 69 transmembrane 70 95 cytoplasmic 96 118 transmembrane 119 152 non-cytoplasmic 153 172 transmembrane 173 181 cytoplasmic 182 204 transmembrane 205 223 non-cytoplasmic 224 248 transmembrane 249 260 cytoplasmic 261 286 transmembrane 287 305 non-cytoplasmic 306 330 transmembrane 331 350 cytoplasmic 351 373 transmembrane 374 388 non-cytoplasmic 389 410 transmembrane 411 430 cytoplasmic 431 451 transmembrane 452 453 non-cytoplasmic
Input: >WP_011815179.1 NCBI__GCF_000015585.1:WP_011815179.1 MKDLRQSIHGEWGSRWAFILAATGSAVGLGNIWRFPYVVGEYGGGAFILIYLACILAIGI PVMMAEILIGRRGRQSPINTMRALPAEFGAGRWWQILGWLGVIAGFLVLSFYSVVAGWSL AYVPYTAAGTFTGTETSQVEAIFNDLLASPWQMLFWHTVFMGATAFIVLRGVQNGLERAV RLLMPILFLLLLVMVGYGMGAGAFVEAMDFMFSPDFSAIGGDAVLVAMGQAFFTLSLGLG AIMAYGSYLSKRSSIPGNSGLIAGADTVIALLAGLAIFPIVLAAGLDPDSGPGLVFVTLS YGFGQMPLGALFGTLFFLLLSFAALTSAISIMEPATAYLVETRGWKRPKAAAAVAAAAWL VGIGSLLAFNVWAGFTIAGLNFQELAEYLSTSVMLPLGGLLMALFAGWVLPRSVTTEELA LPDWVYRGWLVLVRFVVPAAILVVFANSLGLLG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server